TD Asset Management Inc. cut its position in shares of Henry Schein Inc. (NASDAQ:HSIC) by 28.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 211,041 shares of the company’s stock after selling 83,642 shares during the period. TD Asset Management Inc.’s holdings in Henry Schein were worth $34,395,000 as of its most recent SEC filing.

A number of other large investors also recently added to or reduced their stakes in HSIC. Vontobel Asset Management Inc. boosted its position in Henry Schein by 43.7% in the third quarter. Vontobel Asset Management Inc. now owns 117,093 shares of the company’s stock worth $19,085,000 after buying an additional 35,600 shares during the last quarter. Artemis Investment Management LLP boosted its position in Henry Schein by 97.5% in the second quarter. Artemis Investment Management LLP now owns 111,236 shares of the company’s stock worth $19,666,000 after buying an additional 54,920 shares during the last quarter. Bank of Montreal Can acquired a new position in Henry Schein during the second quarter worth about $32,344,000. Chevy Chase Trust Holdings Inc. boosted its position in Henry Schein by 1.0% in the third quarter. Chevy Chase Trust Holdings Inc. now owns 226,219 shares of the company’s stock worth $36,869,000 after buying an additional 2,312 shares during the last quarter. Finally, Eqis Capital Management Inc. boosted its position in Henry Schein by 23.4% in the second quarter. Eqis Capital Management Inc. now owns 1,639 shares of the company’s stock worth $290,000 after buying an additional 311 shares during the last quarter. Institutional investors and hedge funds own 91.35% of the company’s stock.

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Henry Schein Inc. (NASDAQ:HSIC) traded up 0.902% during mid-day trading on Tuesday, reaching $152.725. The company had a trading volume of 103,526 shares. The stock has a 50 day moving average price of $154.22 and a 200 day moving average price of $166.36. The company has a market capitalization of $12.29 billion, a P/E ratio of 25.361 and a beta of 1.09. Henry Schein Inc. has a one year low of $142.64 and a one year high of $183.00.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Wednesday, November 2nd. The company reported $1.68 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.65 by $0.03. Henry Schein had a return on equity of 18.15% and a net margin of 4.40%. The firm earned $2.87 billion during the quarter, compared to analyst estimates of $2.88 billion. During the same period last year, the company posted $1.55 EPS. The business’s quarterly revenue was up 6.7% on a year-over-year basis. On average, equities analysts expect that Henry Schein Inc. will post $6.58 earnings per share for the current fiscal year.

WARNING: This story was originally posted by Daily Political and is owned by of Daily Political. If you are viewing this story on another publication, it was stolen and republished in violation of U.S. & international copyright & trademark laws. The legal version of this story can be accessed at http://www.dailypolitical.com/2016/11/29/henry-schein-inc-hsic-position-decreased-by-td-asset-management-inc.html.

HSIC has been the subject of several recent research reports. Zacks Investment Research cut Henry Schein from a “hold” rating to a “sell” rating in a research report on Monday, August 8th. JPMorgan Chase & Co. reaffirmed a “hold” rating and set a $163.00 price objective on shares of Henry Schein in a research report on Thursday, November 3rd. Goldman Sachs Group Inc. raised Henry Schein from a “neutral” rating to a “buy” rating and set a $185.00 price objective for the company in a research report on Tuesday, October 11th. Robert W. Baird cut Henry Schein from an “outperform” rating to a “neutral” rating and reduced their price objective for the stock from $176.00 to $164.00 in a research report on Friday, October 14th. Finally, Bank of America Corp. initiated coverage on Henry Schein in a research report on Monday, September 12th. They set a “buy” rating and a $185.00 price objective for the company. Seven research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $172.83.

In other news, EVP Mark E. Mlotek sold 2,417 shares of Henry Schein stock in a transaction dated Thursday, November 3rd. The stock was sold at an average price of $155.19, for a total value of $375,094.23. Following the completion of the transaction, the executive vice president now directly owns 40,456 shares of the company’s stock, valued at approximately $6,278,366.64. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. 1.27% of the stock is owned by insiders.

Henry Schein Company Profile

Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.

5 Day Chart for NASDAQ:HSIC

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein Inc. (NASDAQ:HSIC).

Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.